BA
NVAX icon

Bridgewater Associates’s Novavax NVAX Stock Holding History

Bridgewater Associates’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35,356
Closed -$1.82M – 979
2022
Q2 		$1.82M Buy
35,356
+31,335
+779% +$1.62M 0.01% 698
2022
Q1 		$296K Buy
4,021
+1,581
+65% +$141K ﹤0.01% 938
2021
Q4 		$349K Buy
2,440
+1,303
+115% +$224K ﹤0.01% 681
2021
Q3 		$236K Buy
+1,137
New +$251K ﹤0.01% 658

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bridgewater Associates's NVAX Position: Q3 2022 in Review

Bridgewater Associates sold out of Novavax (NVAX) in Q3 2022, closing a stake of 35,356 shares — an estimated $1.82M sold.

Bridgewater Associates first reported a position in NVAX in Q3 2021 and held it in 4 quarters. The position peaked at $1.82M in Q2 2022. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Bridgewater Associates reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Bridgewater Associates sold 35,356 Novavax shares in Q3 2022, an estimated $1.82M.
  • Bridgewater Associates first reported a position in Novavax in Q3 2021 and held it in 4 quarters.
  • Bridgewater Associates's Novavax position peaked at $1.82M in Q2 2022.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.